MedTrace Logo

Study Evaluating Safety Of BMP-655/ACS As An Adjuvant Therapy For Rotator Cuff Repair

NCT00936559 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2012-04-13

No results posted yet for this study

Summary

Study to assess the safety of 3 differing concentrations of BMP-655/ACS in subjects with full thickness Rotator Cuff Tears (RCTs).

Conditions

  • Rotator Cuff Tear

Interventions

BIOLOGICAL

BMP-655/ACS or Standard of Care

Decision was made by Legal to withhold this information

BIOLOGICAL

BMP-655/ACS or Standard of Care

Decision was made by Legal to withhold this information.

BIOLOGICAL

BMP-655/ACS or Standard of Care

Decision was made by Legal to withhold this information,

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2012-02-29
Completion
2012-02-29

Countries

  • Germany
  • Netherlands

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00936559 on ClinicalTrials.gov